Abstract
The use of a combination of daunorubicin and cytosine arabinoside in the treatment of acute myeloid leukaemia in a district general hospital is described. The results in a series of 30 cases are considered.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bernard J., Jacquillat C., Boiron M., Najean Y., Seligmann M., Tanzer J., Weil M., Lortholary P. Essai de traitement des leucémies aiguës lymphoblastiques et myéloblastiques par un antibiotique nouveau: la rubidomycine (13,057 RP). Etude de 61 observations. Presse Med. 1967 Apr 22;75(19):951–955. [PubMed] [Google Scholar]
- Crowther D., Bateman C. J., Vartan C. P., Whitehouse J. M., Malpas J. S., Fairley G. H., Scott R. B. Combination chemotherapy using L-asparaginase, daunorubicin, and cytosine arabinoside in adults with acute myelogenous leukaemia. Br Med J. 1970 Nov 28;4(5734):513–517. doi: 10.1136/bmj.4.5734.513. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Crowther D., Powles R. L., Bateman C. J., Beard M. E., Gauci C. L., Wrigley P. F., Malpas J. S., Fairley G. H., Scott R. B. Management of adult acute myelogenous leukaemia. Br Med J. 1973 Jan 20;1(5846):131–137. doi: 10.1136/bmj.1.5846.131. [DOI] [PMC free article] [PubMed] [Google Scholar]